In NAFLD‐HCC, SCFAs, particularly butyrate, can promote an immunosuppressive environment by enhancing regulatory T cell (Treg) function and inhibiting CD8+T cell cytotoxicity. Here, CD8A is linked to hepatocellular carcinoma.